SCHEMBL31349536

SCHEMBL31349536

CC1(C)OB(c2cc(C(F)(F)F)c3c(c2)ncn3C2CN(S(C)(=O)=O)C2)OC1(C)C

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MAP3K12 Q12852 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ CCNE1 P24864 1/20 0.30
▸ CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31349447 0.81 USP30 (0.42) —
SCHEMBL31349589 0.80 MAP3K12 (0.36) MAP3K12JAK1CCNE1CDK2
SCHEMBL31349450 0.80 ABL1 (0.36) —
SCHEMBL31349584 0.79 MAP3K12 (0.36) MAP3K12JAK1CCNE1CDK2
SCHEMBL31698989 0.73 AAK1 (0.32) —
SCHEMBL31349525 0.71 — —
SCHEMBL17048230 0.70 AURKA (0.36) JAK1
SCHEMBL25315851 0.70 AR (0.34) —
SCHEMBL30506750 0.70 AR (0.34) —
SCHEMBL26023698 0.70 AR (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743078-A2 APOL1 INHIBITORS AND METHODS OF USE Maze Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
WO-2025015104-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2025-01-16 — — WO disclosed
Send feedback